Home/Filings/4/A/0000864268-04-000076
4/A//SEC Filing

BRADLEY PHARMACEUTICALS INC 4/A

Accession 0000864268-04-000076

CIK 0000864268operating

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 10:36 AM ET

Size

15.7 KB

Accession

0000864268-04-000076

Insider Transaction Report

Form 4/AAmended
Period: 2003-11-11
GLASSMAN IRIS
DirectorTreasurer
Transactions
  • Discretionary Transaction

    Stock Options (Right to buy)

    2003-11-11$26.68/sh+1,667$44,4765,000 total
    Exercise: $26.68From: 2006-11-11Exp: 2013-11-10Common Stock (1,667 underlying)
Holdings
  • Stock Options (Right to buy)

    Exercise: $1.31From: 1998-09-12Exp: 2005-09-11Common Stock (18,000 underlying)
    18,000
  • Common Stock

    (indirect: By IRA)
    4,000
  • Common Stock

    (indirect: By Trust)
    15,200
  • Class B Common Stock

    16,403
  • Common Stock

    (indirect: By Trust)
    5,500
  • Common Stock

    (indirect: By Trust)
    6,400
  • Stock Options (Right to buy)

    Exercise: $7.76From: 2004-07-09Exp: 2006-07-08Common Stock (30,000 underlying)
    30,000
  • Common Stock

    39,692
  • Stock Options (Right to buy)

    Exercise: $1.06From: 1995-12-05Exp: 2005-12-04Common Stock (22,878 underlying)
    22,878
  • Stock Options (Right to buy)

    Exercise: $1.31From: 1997-04-12Exp: 2004-04-11Common Stock (50,000 underlying)
    50,000

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000864268

Filing Metadata

Form type
4/A
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 10:36 AM ET
Size
15.7 KB